| Tag | Content |
|---|
EnhancerAtlas ID | HS196-09165 |
Organism | Homo sapiens |
Tissue/cell | ZR75-1 |
Coordinate | chr13:114301680-114302460 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| E2F6 | MA0471.1 | chr13:114302067-114302078 | CTTTCCCGCCC | - | 6.32 | | NR2C2 | MA0504.1 | chr13:114301751-114301766 | TCACCTCTGACCTCT | - | 6.88 | | NR2C2 | MA0504.1 | chr13:114301758-114301773 | TGACCTCTGACCTTC | - | 7.33 | | Nr2f6 | MA0677.1 | chr13:114301758-114301772 | TGACCTCTGACCTT | - | 7.28 | | Rxra | MA0512.2 | chr13:114301758-114301772 | TGACCTCTGACCTT | - | 6.62 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_41872 | chr13:114301246-114302949 | LNCaP |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH13I113647 | chr13 | 114301216 | 114302896 |
|
Enhancer Sequence | TTCCAGCTGG GTTGGCTTTG AGAGTCTGGT GGGATGAACC CTCATGGCTC CACCGTCACT 60
TTGAGGTGGT GTCACCTCTG ACCTCTGACC TTCAGCATGG CATGACCTCG CTGAGGTGAC 120
CCTGGTGTCC CACATATCAC CCTGAGTGTT CTTAATACAC AGTCGAGGGC TGTGTTCATT 180
GGACTATTCT GGTGTCACCG CCCACTTCAT TTCTGTGCCT GGCAGCACTT TTACTCCTGG 240
TTGGGAGCAT GACCGCCTCC CAGTTCAGCT TCCTCCTGCG TCCCAAGTGA GCGGGGCGGC 300
TGTCCTCGAG GACTCCGGGC TCACAGCCAA CCTGCTGGCA CGGCTCGAGG ACTCCGGGCT 360
CACAGCCAAC CTGCTGGCAC GGCCGCCCTT TCCCGCCCTG CCTCGGGTGA GCCAAGGACT 420
TGTCTTCTGC TTCCTGGGTT CCTGAAAGAG CTCTCCTCTG ATTTCTCAAA GGCAAAATAA 480
AACTCAGATT TAAGTCTTTG GTGCGTAGCC CCTAATTTCC TTCCCTTTCT CTGAATCCTC 540
ACTGCCCAGC ATGATGGACC GGCCTGGGCT CAGGACCTGA TTCCACAGGC TCCCAGCCCT 600
CCCACAGGTA CCGTGTCTTC TGTGCTGGTG TCGCACCCGC CGGCCACCGC CACCCTGCGT 660
CTTAGACGTC CCGCCGCAGC TGTGTTTCCA CCTCATCTCC AGCTTGAGTG GCAGCCAGCG 720
GCGCCACCTG CACACGAGCC CCCTCCATTC GAGAAGCACA GACTATGAGT GTGGCCACGC 780
|
